Pegteograstim in Children With Solid Tumors

Clinical trial NCT02787876 · UNKNOWN

Trial details

NCT number: NCT02787876
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy Induced Neutropenia Pediatric Solid Tumor

Start date: 2016-10-04
Primary completion: 2018-10-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.